tenk.fyi

INTENSITY THERAPEUTICS, INC.

INTSNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$11.6M

28.7% YoY

EPS

$-8.56

70.7% YoY

Cash

$11.9M

360.3% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro